Journal article
Virtual screening and biophysical studies lead to HSP90 inhibitors
R Huang, DM Ayine-Tora, MN Muhammad Rosdi, Y Li, J Reynisson, IKH Leung
Bioorganic and Medicinal Chemistry Letters | PERGAMON-ELSEVIER SCIENCE LTD | Published : 2017
Abstract
Heat shock protein 90 (HSP90) is a molecular chaperone that plays important functional roles in cells. The chaperone activity of HSP90 is regulated by the hydrolysis of ATP at the protein's N-terminal domain. HSP90, in particular the N-terminal domain, is a current inhibition target for therapeutic treatments of cancers. This paper describes an application of virtual screening, thermal shift assaying and protein NMR spectroscopy leading to the discovery of HSP90 inhibitors that contain the resorcinol structure. The resorcinol scaffold can be found in a class of HSP90 inhibitors that are currently undergoing clinical trials. The proved success of the resorcinol moiety in HSP90 inhibitors vali..
View full abstractGrants
Funding Acknowledgements
We thank Biochemical Society, Health Research Council of New Zealand, Neurological Foundation of New Zealand and The University of Auckland Faculty Research Development Fund for funding. We thank Dr M. Schmitz for maintenance of the NMR facility and Ms K. Boxen for the DNA sequencing service. JR is on the inventors' list for Luminespib, a HSP90 inhibitor in clinical trials. All other authors declare no competing financial interest.